Reiff A - Search Results

1

Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.

Reyhan I, Zhukov OS, Lagier RJ, Bridgforth RF, Williams GJ, Popov JM, Naides SJ, Reiff A. Reyhan I, et al. Among authors: reiff a. Pediatr Rheumatol Online J. 2021 Feb 16;19(1):14. doi: 10.1186/s12969-021-00502-8. Pediatr Rheumatol Online J. 2021. PMID: 33593401 Free PMC article.

2

Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.

Reiff A, Lovell DJ, Adelsberg JV, Kiss MH, Goodman S, Zavaler MF, Chen PY, Bolognese JA, Cavanaugh P Jr, Reicin AS, Giannini EH. Reiff A, et al. J Rheumatol. 2006 May;33(5):985-95. Epub 2006 Apr 1. J Rheumatol. 2006. PMID: 16583464 Clinical Trial.

3

Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.

Reiff A, Rawlings DJ, Shaham B, Franke E, Richardson L, Szer IS, Bernstein BH. Reiff A, et al. J Rheumatol. 1997 Dec;24(12):2436-43. J Rheumatol. 1997. PMID: 9415655

4

Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.

Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A. Takei S, et al. Among authors: reiff a. J Rheumatol. 2001 Jul;28(7):1677-80. J Rheumatol. 2001. PMID: 11469478

5

Prevalence of anti-neutrophil cytoplasmic antibodies (ANCA) in juvenile chronic arthritis.

Speckmaier M, Röther E, Terreri T, Reiff A, Metzger D, Schuchmann L, Forster J, Peter HH, Brandis M. Speckmaier M, et al. Among authors: reiff a. Clin Exp Rheumatol. 1996 Mar-Apr;14(2):211-6. Clin Exp Rheumatol. 1996. PMID: 8737731

6

High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis.

Reiff A, Shaham B, Wood BP, Bernstein BH, Stanley P, Szer IS. Reiff A, et al. Clin Exp Rheumatol. 1995 Jan-Feb;13(1):113-8. Clin Exp Rheumatol. 1995. PMID: 7774090 Clinical Trial.

7

Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.

Chang CY, Meyer RM, Reiff AO. Chang CY, et al. Arthritis Care Res (Hoboken). 2015 May;67(5):658-66. doi: 10.1002/acr.22477. Arthritis Care Res (Hoboken). 2015. PMID: 25220674 Free article.

8

B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.

Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W. Hong SD, et al. Among authors: reiff a. Arthritis Rheum. 2009 Nov;60(11):3400-9. doi: 10.1002/art.24902. Arthritis Rheum. 2009. PMID: 19877053 Free article.

9

The use of anakinra in juvenile arthritis.

Reiff A. Reiff A. Curr Rheumatol Rep. 2005 Dec;7(6):434-40. doi: 10.1007/s11926-005-0047-2. Curr Rheumatol Rep. 2005. PMID: 16303102 Review.

10

Developments in the treatment of juvenile arthritis.

Reiff AO. Reiff AO. Expert Opin Pharmacother. 2004 Jul;5(7):1485-96. doi: 10.1517/14656566.5.7.1485. Expert Opin Pharmacother. 2004. PMID: 15212599 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page